Dengue Vaccination Campaign Launched in General Villegas to Prevent Severe Cases
Dengue Vaccine Rollout Begins Across Argentina, Targeting High-Risk Groups
Buenos Aires, Argentina – A nationwide campaign to vaccinate against dengue fever has begun, with hospitals and health centers across Argentina administering the vaccine to eligible individuals. The initiative aims to prevent severe cases of the mosquito-borne illness, which has seen a surge in recent months.
“We are focusing on vaccinating people aged 15 to 59 who have previously contracted dengue,” explained a spokesperson from the Hospital Julio de Vedia in Buenos Aires. “This group is at higher risk of developing serious complications from future infections.”
The vaccine, which has been approved by Argentine health authorities, has shown promising results in clinical trials, significantly reducing the risk of hospitalization and severe dengue.
Cities like General Villegas, Rafaela, and Olavarría have already launched their vaccination campaigns, with health officials urging residents to take advantage of this preventative measure.
“this is a crucial step in protecting our community from the threat of dengue,” said the mayor of Olavarría.”We encourage everyone who is eligible to get vaccinated and help us curb the spread of this disease.”
The campaign comes as argentina experiences an increase in dengue cases, prompting concerns about a potential outbreak. Health officials are working to raise awareness about the importance of mosquito control measures, such as eliminating standing water and using insect repellent.
The vaccination program is expected to continue throughout the year, with health authorities closely monitoring its progress and impact on dengue transmission rates.
Argentina Battles Dengue Surge with Nationwide Vaccine Rollout
Buenos Aires, Argentina – In response to a recent surge in dengue fever cases, Argentina has launched a nationwide vaccination campaign targeting high-risk groups. Hospitals and health centers across the country are administering the vaccine to individuals aged 15 to 59 who have previously contracted dengue.
“This group is at higher risk of developing serious complications from future infections,” a spokesperson explained from the Hospital Julio de Vedia in Buenos Aires.
The vaccine, approved by Argentine health authorities, has demonstrated significant efficacy in clinical trials, demonstrably reducing the risk of hospitalization and severe dengue.
Cities, including General Villegas, Rafaela, and Olavarría, have initiated their vaccination programs. Local officials are actively urging eligible residents to participate in this preventative measure.
“This is a crucial step in protecting our community from the threat of dengue,” stated the mayor of olavarría. “We encourage everyone who is eligible to get vaccinated and help us curb the spread of this disease.”
The vaccination program coincides with Argentina facing an increase in dengue cases, raising concerns about a potential outbreak.Health officials are working diligently to raise awareness about mosquito control measures, emphasizing the importance of eliminating standing water and using insect repellent.
The vaccination drive is expected to continue throughout the year,with health authorities closely monitoring its progress and impact on dengue transmission rates.